varespladib has been researched along with Sepsis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abraham, E; Dmitrienko, A; Fukiishi, Y; Laterre, PF; Steingrub, J; Zeiher, BG | 1 |
1 trial(s) available for varespladib and Sepsis
Article | Year |
---|---|
LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis.
Topics: Acetates; Double-Blind Method; Europe; Female; Group II Phospholipases A2; Humans; Indoles; Infusions, Intravenous; Keto Acids; Male; Middle Aged; Multiple Organ Failure; Phospholipases A; Phospholipases A2; Risk; Sepsis; United States | 2005 |